SP2509

SP2509
Item number Size Datasheet Manual SDS Delivery time Quantity Price
Cay15487-1 1 mg -

5 - 10 business days*

32.00€
Cay15487-5 5 mg -

5 - 10 business days*

87.00€
Cay15487-10 10 mg -

5 - 10 business days*

157.00€
Cay15487-25 25 mg -

5 - 10 business days*

352.00€
 
Lysine-specific demethylase 1 (LSD1) is a protein lysine demethylase that specifically... more
Product information "SP2509"
Lysine-specific demethylase 1 (LSD1) is a protein lysine demethylase that specifically demethylates histone H3 lysine 4 (H3K4), resulting in transcriptional repression. SP2509 is a reversible inhibitor of LSD1 (IC50 = 13 nM). It has no effect on monoamine oxidases A and B. SP2509 attenuates the binding of LSD1 to CoREST, allowing increased methylation of H3K4 and driving increased expression of p21, p27, and CCAAT/enhancer binding protein alpha in cultured acute myeloid leukemia (AML) cells. It improves survival of mice with AML xenografts when given (25 mg/kg biweekly via intraperitoneal injection) for three weeks. Co-treatment of SP2509 with the pan-HDAC inhibitor panobinostat (Cay-13280) synergistically kills AML cells in vitro and improves survival of mice engrafted with AML cells.
Keywords: HCI-2509, LSD1 Inhibitor VII, 3-(4-morpholinylsulfonyl)-benzoic acid (2E)-2-[1-(5-chloro-2-hydroxyphenyl)ethylidene]hydrazide
Supplier: Cayman Chemical
Supplier-Nr: 15487

Properties

Application: LSD1 inhibitor
MW: 437.9 D
Formula: C19H20ClN3O5S
Purity: >98%
Format: Crystalline Solid

Database Information

CAS : 1423715-09-6| Find alternatives
KEGG ID : K11450 | Find alternatives

Handling & Safety

Storage: -20°C
Shipping: +20°C (International: -20°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "SP2509"
Write a review
or to review a product.
Viewed